Rigel Pharma (RIGL) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $34.42 +4.59%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $29.8 million versus the consensus estimate of $23.82 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
